Yatin Suneja
Stock Analyst at Guggenheim
(4.43)
# 317
Out of 5,042 analysts
143
Total ratings
58.4%
Success rate
16.2%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $350 | $173.97 | +101.18% | 3 | Oct 17, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $101 → $150 | $90.76 | +65.27% | 3 | Oct 10, 2025 | |
| ACET Adicet Bio | Maintains: Buy | $7 → $8 | $0.89 | +798.88% | 3 | Oct 8, 2025 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $80 → $20 | $9.52 | +110.08% | 4 | Sep 30, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $1,070 | $817.32 | +30.92% | 13 | Sep 18, 2025 | |
| ROIV Roivant Sciences | Maintains: Buy | $15 → $21 | $18.22 | +15.26% | 3 | Sep 18, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $55 → $48 | $47.98 | +0.04% | 4 | Sep 10, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $92 → $100 | $32.92 | +203.77% | 2 | Sep 9, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | $75 | $12.13 | +518.30% | 1 | Aug 18, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $25 → $15 | $2.47 | +507.29% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $810 → $815 | $577.95 | +41.02% | 7 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $144.00 | +21.53% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.21 | +517.58% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $18 | $4.51 | +299.11% | 2 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $90 | $35.07 | +156.63% | 13 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $13.95 | +107.89% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $13.53 | -11.31% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.69 | +306.50% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.40 | +614.29% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $18.94 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $23.90 | +88.32% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.63 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $13.70 | +228.47% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.02 | -9.17% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.97 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $23.37 | +178.13% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.53 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $26.72 | +236.83% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $129.55 | -3.51% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.33 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $40.76 | +20.22% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $11.98 | +359.10% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $149.89 | +133.50% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.10 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.52 | +54.64% | 1 | May 31, 2022 |
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $155 → $350
Current: $173.97
Upside: +101.18%
ABIVAX Société Anonyme
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $90.76
Upside: +65.27%
Adicet Bio
Oct 8, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $0.89
Upside: +798.88%
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $9.52
Upside: +110.08%
argenx SE
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $817.32
Upside: +30.92%
Roivant Sciences
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $18.22
Upside: +15.26%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $55 → $48
Current: $47.98
Upside: +0.04%
Dianthus Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $32.92
Upside: +203.77%
Forte Biosciences
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $12.13
Upside: +518.30%
Cabaletta Bio
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.47
Upside: +507.29%
Aug 4, 2025
Maintains: Buy
Price Target: $810 → $815
Current: $577.95
Upside: +41.02%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $144.00
Upside: +21.53%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $4.21
Upside: +517.58%
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $4.51
Upside: +299.11%
May 28, 2025
Maintains: Buy
Price Target: $54 → $90
Current: $35.07
Upside: +156.63%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $13.95
Upside: +107.89%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $13.53
Upside: -11.31%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $3.69
Upside: +306.50%
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.40
Upside: +614.29%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $18.94
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $23.90
Upside: +88.32%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.63
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $13.70
Upside: +228.47%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.02
Upside: -9.17%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.97
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $23.37
Upside: +178.13%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $29.53
Upside: -
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $26.72
Upside: +236.83%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $129.55
Upside: -3.51%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.33
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $40.76
Upside: +20.22%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $11.98
Upside: +359.10%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $149.89
Upside: +133.50%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.10
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.52
Upside: +54.64%